Failure to confirm a sodium–glucose cotransporter 2 inhibitor‐induced hematopoietic effect in non‐diabetic rats with renal anemia

AIMS/INTRODUCTION: Clinical studies have shown that treatment with inhibitors of sodium–glucose cotransporter 2 (SGLT2) significantly increases the hematocrit in patients with type 2 diabetes. To investigate whether SGLT2 inhibitors directly promote erythropoietin production independently on blood g...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Daisuke, Konishi, Yoshio, Morikawa, Takashi, Kobara, Hideki, Masaki, Tsutomu, Hitomi, Hirofumhi, Osafune, Kenji, Nakano, Daisuke, Kittikulsuth, Wararat, Nishiyama, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378420/
https://www.ncbi.nlm.nih.gov/pubmed/31880858
http://dx.doi.org/10.1111/jdi.13205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378420/
https://www.ncbi.nlm.nih.gov/pubmed/31880858
http://dx.doi.org/10.1111/jdi.13205

Ejemplares similares